organization · Reporting owner
LABCORP HOLDINGS INC.
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SEQUENOM INCSQNM · Entity 182543 | 10% owner | September 07, 2016 | September 07, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SEQUENOM INC
Report date September 07, 2016 · Filed September 07, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.001SEC Table I · non-derivative | Direct | 119,551,297 |
Reported balance
After 2016-09-07 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2016-09-07 · Purchase · Acquired 36,649,440 · Balance 119,551,297 F1: These shares were acquired pursuant to an Agreement and Plan of Merger, dated July 26, 2016 (the "Merger Agreement"), by and among the Reporting Person, Savoy Acquisition Corp., a wholly owned subsidiary of the Reporting Person ("Purchaser"), and the Issuer. Pursuant to the Merger Agreement, the Reporting Person acquired all of the outstanding shares of the Issuer in a two-step transaction involving, first, the completion of a tender offer by the Reporting Person and Purchaser (the "Tender Offer"), and, second, a back-end merger for 100% ownership pursuant to which Purchaser merged with and into the Issuer and the Reporting Person acquired all of the outstanding shares of the Issuer that were not acquired by Purchaser in the Tender Offer. The acquired shares reported herein were acquired by the Reporting Person as part of the second step of the transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were acquired pursuant to an Agreement and Plan of Merger, dated July 26, 2016 (the "Merger Agreement"), by and among the Reporting Person, Savoy Acquisition Corp., a wholly owned subsidiary of the Reporting Person ("Purchaser"), and the Issuer. Pursuant to the Merger Agreement, the Reporting Person acquired all of the outstanding shares of the Issuer in a two-step transaction involving, first, the completion of a tender offer by the Reporting Person and Purchaser (the "Tender Offer"), and, second, a back-end merger for 100% ownership pursuant to which Purchaser merged with and into the Issuer and the Reporting Person acquired all of the outstanding shares of the Issuer that were not acquired by Purchaser in the Tender Offer. The acquired shares reported herein were acquired by the Reporting Person as part of the second step of the transaction.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Fortrea Holdings Inc.
Report date June 20, 2023 · Filed June 21, 2023
Section 16 reporting ended · disclosed 2023-06-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-06-20 transaction · row 1
1 source rowRow 1 · 2023-06-20 · Other · Disposed 100 · Balance 0 F1: In connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), (a) Fortrea will convert the outstanding shares of Fortrea common stock currently held by Labcorp into 88,765,089 shares of Fortrea common stock and (b) Labcorp will distribute all of the outstanding shares of Fortrea common stock held by Labcorp to Labcorp common stockholders as of the record date, which was the close of business on June 20, 2023 (the "Record Date"). For each share of Labcorp common stock held on the Record Date, Labcorp will distribute one share of Fortrea common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: In connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), (a) Fortrea will convert the outstanding shares of Fortrea common stock currently held by Labcorp into 88,765,089 shares of Fortrea common stock and (b) Labcorp will distribute all of the outstanding shares of Fortrea common stock held by Labcorp to Labcorp common stockholders as of the record date, which was the close of business on June 20, 2023 (the "Record Date"). For each share of Labcorp common stock held on the Record Date, Labcorp will distribute one share of Fortrea common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 20, 2023 Filed Jun 21, 2023 20:42 UTC | Fortrea Holdings Inc. FTRE · Entity 4623 | OtherCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-019164 · form4.xml · nonDerivative · entry 1 LABORATORY CORP OF AMERICA HOLDINGS · CIK 0000920148 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: In connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), (a) Fortrea will convert the outstanding shares of Fortrea common stock currently held by Labcorp into 88,765,089 shares of Fortrea common stock and (b) Labcorp will distribute all of the outstanding shares of Fortrea common stock held by Labcorp to Labcorp common stockholders as of the record date, which was the close of business on June 20, 2023 (the "Record Date"). For each share of Labcorp common stock held on the Record Date, Labcorp will distribute one share of Fortrea common stock. Read SEC document |
| September 07, 2016 Filed Sep 7, 2016 21:22 UTC | SEQUENOM INC SQNM · Entity 182543 | PurchaseCommon Stock, par value $0.001 | 36,649,440 | $2.40 | $87,958,656.00 |
DisclosureSEC source: 0001123292-16-002653 · edgar.xml · nonDerivative · entry 1 LABORATORY CORP OF AMERICA HOLDINGS · CIK 0000920148 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,551,297 F1 · kind: These shares were acquired pursuant to an Agreement and Plan of Merger, dated July 26, 2016 (the "Merger Agreement"), by and among the Reporting Person, Savoy Acquisition Corp., a wholly owned subsidiary of the Reporting Person ("Purchaser"), and the Issuer. Pursuant to the Merger Agreement, the Reporting Person acquired all of the outstanding shares of the Issuer in a two-step transaction involving, first, the completion of a tender offer by the Reporting Person and Purchaser (the "Tender Offer"), and, second, a back-end merger for 100% ownership pursuant to which Purchaser merged with and into the Issuer and the Reporting Person acquired all of the outstanding shares of the Issuer that were not acquired by Purchaser in the Tender Offer. The acquired shares reported herein were acquired by the Reporting Person as part of the second step of the transaction. F1 · shares: These shares were acquired pursuant to an Agreement and Plan of Merger, dated July 26, 2016 (the "Merger Agreement"), by and among the Reporting Person, Savoy Acquisition Corp., a wholly owned subsidiary of the Reporting Person ("Purchaser"), and the Issuer. Pursuant to the Merger Agreement, the Reporting Person acquired all of the outstanding shares of the Issuer in a two-step transaction involving, first, the completion of a tender offer by the Reporting Person and Purchaser (the "Tender Offer"), and, second, a back-end merger for 100% ownership pursuant to which Purchaser merged with and into the Issuer and the Reporting Person acquired all of the outstanding shares of the Issuer that were not acquired by Purchaser in the Tender Offer. The acquired shares reported herein were acquired by the Reporting Person as part of the second step of the transaction. F1 · balance_after: These shares were acquired pursuant to an Agreement and Plan of Merger, dated July 26, 2016 (the "Merger Agreement"), by and among the Reporting Person, Savoy Acquisition Corp., a wholly owned subsidiary of the Reporting Person ("Purchaser"), and the Issuer. Pursuant to the Merger Agreement, the Reporting Person acquired all of the outstanding shares of the Issuer in a two-step transaction involving, first, the completion of a tender offer by the Reporting Person and Purchaser (the "Tender Offer"), and, second, a back-end merger for 100% ownership pursuant to which Purchaser merged with and into the Issuer and the Reporting Person acquired all of the outstanding shares of the Issuer that were not acquired by Purchaser in the Tender Offer. The acquired shares reported herein were acquired by the Reporting Person as part of the second step of the transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.